Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

Learn more about whether Halozyme Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Detailed price information for Immix Biopharma Inc (IMMX-Q) from The Globe and Mail including charting and trades.

The financing includes leading U.S. biotechnology institutional investors and mutual funds. Morgan Stanley acted as the sole book-running manager for the offering. Citizens Capital Markets and Mizuho ...

What started as a fun peek into ancestry quickly turned into life-altering information for many of these people. The stories ...

Aficamten, a first-in-class cardiac myosin inhibitor, offers a new treatment option for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Clinical trials SEQUOIA-HCM and MAPLE-HCM showed ...

Tributes have poured in after the death of Muriel Abbott, Springfield House, Mohill, Co. Leitrim on Saturday December 20th, ...

Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...

The death occurred peacefully at Naas General Hospital, surrounded by his loving family on Friday, December 19, 2025 of Donal ...